Matches in Wikidata for { <http://www.wikidata.org/entity/Q37163139> ?p ?o ?g. }
- Q37163139 description "article científic" @default.
- Q37163139 description "article scientifique" @default.
- Q37163139 description "articolo scientifico" @default.
- Q37163139 description "artigo científico" @default.
- Q37163139 description "artículu científicu espublizáu en 2015" @default.
- Q37163139 description "bilimsel makale" @default.
- Q37163139 description "scientific article published on 20 March 2015" @default.
- Q37163139 description "vedecký článok" @default.
- Q37163139 description "vetenskaplig artikel" @default.
- Q37163139 description "videnskabelig artikel" @default.
- Q37163139 description "vědecký článek" @default.
- Q37163139 description "wetenschappelijk artikel" @default.
- Q37163139 description "wissenschaftlicher Artikel" @default.
- Q37163139 description "наукова стаття, опублікована в березні 2015" @default.
- Q37163139 description "научни чланак" @default.
- Q37163139 description "مقالة علمية نشرت في 20 مارس 2015" @default.
- Q37163139 name "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 name "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 name "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies." @default.
- Q37163139 type Item @default.
- Q37163139 label "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 label "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 label "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies." @default.
- Q37163139 prefLabel "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 prefLabel "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 prefLabel "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies." @default.
- Q37163139 P1433 Q37163139-82801920-6DD8-4DC8-B0F8-6BB55B69F2E7 @default.
- Q37163139 P1476 Q37163139-EEDC583D-62FE-4400-9BF6-1E1E868B14E7 @default.
- Q37163139 P2093 Q37163139-02108370-1358-4E78-8643-610B174BAB50 @default.
- Q37163139 P2093 Q37163139-0287E2C0-19D4-4A76-B6EF-EF00C9659D45 @default.
- Q37163139 P2093 Q37163139-0E2BF89B-62ED-4A3A-BD9D-B29B7A279273 @default.
- Q37163139 P2093 Q37163139-1EBA7110-AF23-4F5C-A6B4-8C495E845B58 @default.
- Q37163139 P2093 Q37163139-2B7E42A7-6ADE-405F-BF2C-53914A11E2AB @default.
- Q37163139 P2093 Q37163139-3807659C-FF82-467B-8369-2229B1C851C0 @default.
- Q37163139 P2093 Q37163139-651618FD-E2F4-4DFB-BDE3-99A0B2A27074 @default.
- Q37163139 P2093 Q37163139-CBEFC3D3-7787-437E-B097-FA006EE4E77B @default.
- Q37163139 P2860 Q37163139-0BC2E440-F800-47C7-98E1-75BED5685351 @default.
- Q37163139 P2860 Q37163139-1454C189-4F4B-4371-A998-872A09557841 @default.
- Q37163139 P2860 Q37163139-3198E47D-338C-413D-9BDE-55CBFE7F2280 @default.
- Q37163139 P2860 Q37163139-3FC43335-4F99-41C9-AC7F-60FDE84DA8DB @default.
- Q37163139 P2860 Q37163139-40DD4E2F-5799-4A83-9C92-F5C5D02164D1 @default.
- Q37163139 P2860 Q37163139-46979DF3-8B61-441D-A666-D8A9654D372E @default.
- Q37163139 P2860 Q37163139-4C9C39F2-3697-4190-A05C-53126C24F99A @default.
- Q37163139 P2860 Q37163139-509C3846-B5AA-49BF-9D68-DE4A3C7386B2 @default.
- Q37163139 P2860 Q37163139-5A1E5395-CFBA-409D-8D3F-1D35176AAF27 @default.
- Q37163139 P2860 Q37163139-5D3A9C2F-1101-4245-9699-2FA5BD86DA54 @default.
- Q37163139 P2860 Q37163139-60A12C43-EF1C-48B8-9A46-2209BE295FAC @default.
- Q37163139 P2860 Q37163139-60AF48AB-4CE2-4AAB-91B0-3059B185EC7D @default.
- Q37163139 P2860 Q37163139-6ABA78B0-59BC-45AC-91AB-CEAC3142751B @default.
- Q37163139 P2860 Q37163139-6D5E175F-25E1-4902-A964-6F4FC73E6725 @default.
- Q37163139 P2860 Q37163139-6E0B5260-EC9E-4D46-929B-F00EB8928753 @default.
- Q37163139 P2860 Q37163139-724B765C-6894-4BAD-B304-DAD30EF39B42 @default.
- Q37163139 P2860 Q37163139-81A44A95-BB64-4EAC-8839-2C2F7C7BEB05 @default.
- Q37163139 P2860 Q37163139-820C3F4C-81EE-49E0-BCAA-EFCFD24A234C @default.
- Q37163139 P2860 Q37163139-9F944533-0073-431A-8D3A-26C474BD7D98 @default.
- Q37163139 P2860 Q37163139-B10CCF53-3DB7-4103-9654-0B0F093ADFC3 @default.
- Q37163139 P2860 Q37163139-B7163C65-28B2-4064-AEE0-443BFECDD14A @default.
- Q37163139 P2860 Q37163139-BCDDD0E6-A279-444F-8619-7CF96C167850 @default.
- Q37163139 P2860 Q37163139-C4EBDFC5-98FD-40C5-B283-49837306EF93 @default.
- Q37163139 P2860 Q37163139-C51E11EE-C9BA-4D91-B695-9CC7B74DB418 @default.
- Q37163139 P2860 Q37163139-CE49EBC8-A63C-4AB8-8810-2D3D35B1EAA3 @default.
- Q37163139 P2860 Q37163139-D36C9528-E298-4626-9D15-9CEED2130B03 @default.
- Q37163139 P2860 Q37163139-D547D814-FDA0-4D01-8DB2-5298E3990FBD @default.
- Q37163139 P2860 Q37163139-D6F75D89-6A3C-4A39-94E0-E5C5466C8423 @default.
- Q37163139 P2860 Q37163139-DDA2E225-D630-4DA1-B4C4-5936C8C136C0 @default.
- Q37163139 P2860 Q37163139-E4FBD384-98D3-4BAE-805C-E8322667B2E6 @default.
- Q37163139 P2860 Q37163139-E662ECAA-188D-4ABF-9D06-A4CDA1E645CA @default.
- Q37163139 P2860 Q37163139-E9A45301-AB1C-4394-9053-C9B8474AC632 @default.
- Q37163139 P2860 Q37163139-EA1DC201-3C74-49F3-B024-FFB2D1EA7D23 @default.
- Q37163139 P2860 Q37163139-ECD30E60-EF22-4C6E-A210-D47A8C9E45D1 @default.
- Q37163139 P2860 Q37163139-EE83FEC3-D67F-4DB5-B871-1E96A214A031 @default.
- Q37163139 P2860 Q37163139-F809A617-9EDD-4D30-AEF0-5399863E94DC @default.
- Q37163139 P2888 Q37163139-72CABC01-A581-4F59-BD64-94E15C0A3DB0 @default.
- Q37163139 P304 Q37163139-08B71623-112B-4180-8F15-F0E14362EC29 @default.
- Q37163139 P31 Q37163139-05E796F7-51CD-4A47-B622-05DA2807050D @default.
- Q37163139 P356 Q37163139-E95E6DA5-20C1-41E9-9064-BD9ABDAA4CED @default.
- Q37163139 P433 Q37163139-94BD5AE5-C6B7-45AD-9317-7DBBB6017197 @default.
- Q37163139 P478 Q37163139-4C56CC1E-1281-4517-BCBB-4B751495997F @default.
- Q37163139 P50 Q37163139-270DD807-7E68-46F1-8FB2-A82BC75E5258 @default.
- Q37163139 P577 Q37163139-67D7F940-0EE1-49D3-9319-ABAFD92CCCE5 @default.
- Q37163139 P5875 Q37163139-D3C9442C-E163-4D69-A2D5-EA4E4A9D3F0D @default.
- Q37163139 P698 Q37163139-472A1F08-10A9-4D6F-8B75-4B244ABDCE33 @default.
- Q37163139 P921 Q37163139-1757D3DC-CCF8-4AA6-8B33-ADE0E542E994 @default.
- Q37163139 P921 Q37163139-8097F520-FAE7-45AF-9511-BE7109252A24 @default.
- Q37163139 P932 Q37163139-6F1A36BD-8B60-4DB6-BE03-CA31C758CDB0 @default.
- Q37163139 P356 S00280-015-2705-Z @default.
- Q37163139 P698 25791363 @default.
- Q37163139 P1433 Q326137 @default.
- Q37163139 P1476 "Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies" @default.
- Q37163139 P2093 "Eric Sherman" @default.
- Q37163139 P2093 "Jinhui Li" @default.
- Q37163139 P2093 "Louis M Weiner" @default.
- Q37163139 P2093 "Michael Bookman" @default.
- Q37163139 P2093 "Neal J Meropol" @default.
- Q37163139 P2093 "Roger B Cohen" @default.
- Q37163139 P2093 "Roland Knoblauch" @default.
- Q37163139 P2093 "Trilok Parekh" @default.
- Q37163139 P2860 Q27860904 @default.
- Q37163139 P2860 Q30925921 @default.
- Q37163139 P2860 Q30998417 @default.